In our cohort of 224 PD-1/PD-L1 inhibitor–related PNS cases, central nervous system presentations—such as encephalomyelitis, limbic encephalitis, and subacute cerebellar degeneration—were more frequent than peripheral neuropathies, neuromuscular junction disorders, or myopathies. The gene discussed is PDCD1; the disease is peripheral neuropathy.